Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
The subcellular localization of organelles, mRNAs and proteins is particularly challenging in neurons. Owing to their extended morphology, with axons in humans exceeding a meter in length, in addition to which they are not renewed but persist for the entire lifespan, it is no surprise that neurons are highly vulnerable to any perturbation of their sophisticated transport machinery. There is emerging evidence that impaired transport is not only causative for a range of motor disorders, but possibly also for Alzheimer's disease (AD) and related neurodegenerative disorders. Support for this hypothesis comes from transgenic animal models. Overexpression of human tau and amyloid precursor protein (APP) in mice and flies models the key hallmark histopathological characteristics of AD, such as somatodendritic accumulation of phosphorylated forms of tau and β‐amyloid (Aβ) peptide‐containing amyloid plaques, as well as axonopathy. The latter has also been demonstrated in mutant mice with altered levels of Alzheimer‐associated genes, such as presenilin (PS). In Aβ‐producing APP transgenic mice, axonopathy was observed before the onset of plaque formation and tau hyperphosphorylation. In human AD brain, an axonopathy was revealed for early but not late Braak stages. The overall picture is that key players in AD, such as tau, APP and PS, perturb axonal transport early on in AD, causing impaired synaptic plasticity and reducing survival rates. It will be challenging to determine the molecular mechanisms of these different axonopathies, as this might assist in the development of new therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · cited 1×
“The major component of the Ab plaques is a 40–42-amino acid aggregated polypeptide (Ab), which is derived by proteolysis from the larger amyloid precursor protein (APP) (Glenner and Wong 1984; Masters et al. 1985).”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“genes encoding presenilin 1 and 2 (PS1 and PS2), the latter being components of the c-secretase complex (Van Broeckhoven et al. 1992; Sherrington et al. 1995).”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“…generates p3 fragments and the AICD. aSecretase cleavage of APP takes place mainly in the Golgi apparatus and at the plasma membrane (Lammich et al. 1999; Skovronsky et al. 2000), whereas BACE1 is thought to be mostly active in endosomes (Koo and Squazzo 1994; Vassar et al. 1999; Huse et al. 2000).”
BackgroundAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 2×
“…axonal terminals appear to be sufficient to generate Ab (Kawarabayashi et al. 1993; Uchihara et al. 1995; Lazarov et al. 2002; Roher et al. 2002; Kamenetz et al. 2003; Smith et al. 2003; Chen et al. 2004b), axonal transport kinetics of BACE and PS1 are different from those of APP (Lazarov et…”
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 3×
“A role for transport in tauopathies is also evident from an extensive transcriptomic study of P301L mutant tau transgenic mice (Gotz et al. 2001a) and P301L tau-transfected SY5Y neuroblastoma cells (Ferrari et al. 2003; Pennanen and Gotz 2005) using three annotation databases.”
BackgroundMethodNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“This has been shown for visual cortex, superior temporal sulcus, entorhinal cortex and area 9 (Leuba and Kraftsik 1994; Gomez-Isla et al. 1997; Giannakopoulos et al. 2003).”
BackgroundMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 1×
“The discovery of both exonic and intronic tau mutations in FTDP-17 established that dysfunction of tau in itself can cause neurodegeneration and lead to dementia (Hutton et al. 1998; Poorkaj et al. 1998; Spillantini et al. 1998).”
BackgroundHolcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · cited 1×
“The discovery of both exonic and intronic tau mutations in FTDP-17 established that dysfunction of tau in itself can cause neurodegeneration and lead to dementia (Hutton et al. 1998; Poorkaj et al. 1998; Spillantini et al. 1998).”
BackgroundLewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371 · cited 2×
“…illustrated by the motor phenotype found in P301L tau transgenic mice with expression levels of the transgene similar to endogenous murine tau (Lewis et al. 2000), whereas no motor phenotype has been reported up to 6 months of age in tetracycline-regulated P301L tau transgenic mice with a…”
BackgroundMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 2×
“in lysosomes, synaptic vesicles failing at nerve terminals, and vesicle accumulation in cell bodies suggested that microtubule-dependent transport is impaired in AD (Suzuki and Terry 1967; Scheff et al. 1990; Praprotnik et al. 1996; Terry 1996; Hirai et al. 2001).”
BackgroundGoedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1×
“They are composed of filaments with the major component being tau, a microtubule-associated protein (MAP) (Goedert et al. 1988).”
BackgroundTangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · cited 1×
“This has been shown for visual cortex, superior temporal sulcus, entorhinal cortex and area 9 (Leuba and Kraftsik 1994; Gomez-Isla et al. 1997; Giannakopoulos et al. 2003).”
BackgroundEbneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · cited 2×
“There is a progressive loss of dendritic spines from hippocampal and cortical pyramidal neurons as well as dentate granule cells in AD (reviewed in Fiala et al. 2002).”
BackgroundPrecursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., & Wolfson, L. (1988) · Neurology · doi:10.1212/wnl.38.11.1682 · Cited by 586
Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A., & Goldstein, L. S. B. (2001) · Nature · doi:10.1038/414643a · Cited by 583 · cited 2×
“…993–1006 2006 The Authors BACE and PS1 are transported along the axon (Sheng et al. 2003; Chen et al. 2004b) and it has been proposed that these two APP secretases are specific cargoes of APPcontaining vesicles which are transported by the fast anterograde transport machinery (Kamal et al. 2001).”
BackgroundIshihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564 · cited 9×
“The subsequent use of stronger promoters to drive transgene expression by three laboratories caused a more pronounced but very similar phenotype (Ishihara et al. 1999; Spittaels et al. 1999; Probst et al. 2000) (Fig.”
BackgroundResultInfluentialSpires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 2×
“%) was found extending approximately 20 lm from the plaque edges (Spires et al. 2005).”
BackgroundKamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544
Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease
Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250089017 · Cited by 514 · cited 1×
“…to demonstrate a clear relationship between the severity of dementia and Ab deposition (that is Ab plaques) in human AD brain, whereas a correlation between NFT numbers and severity of dementia has been reported (Crystal et al. 1988; Arriagada et al. 1992; Bierer et al. 1995; Nagy et al. 1996).”
BackgroundTau filament formation in transgenic mice expressing P301L tau
Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495 · cited 3×
“A role for transport in tauopathies is also evident from an extensive transcriptomic study of P301L mutant tau transgenic mice (Gotz et al. 2001a) and P301L tau-transfected SY5Y neuroblastoma cells (Ferrari et al. 2003; Pennanen and Gotz 2005) using three annotation databases.”
BackgroundMethodSelf-citationThe JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins
Yasuda, J., Whitmarsh, A. J., Cavanagh, J., Sharma, M., & Davis, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7245 · Cited by 458 · cited 2×
“As both APP and JIP1b have been demonstrated to activate the JNK signaling pathway (Yasuda et al. 1999; Kogel et al. 2005; Leyssen et al. 2005), which also affects kinesin transport (Nagata et al.”
BackgroundProteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice
David, D. C., Hauptmann, S., Scherping, I., Schuessel, K., Keil, U., Rizzu, P., Ravid, R., Dröse, S., Brandt, U., Müller, W. E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500356200 · Cited by 447 · cited 2×
“…control brain, and a serial analysis of gene expression analysis of P301L tau-transgenic amygdalae compared with amygdalae dissected from controls) share regulated genes involved in just two categories, one of which is intracellular protein transport (David et al. 2005b; Hoerndli et al. 2005).”
BackgroundResultSelf-citationQuantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 1×
“…98, 993–1006 2006 The Authors in lysosomes, synaptic vesicles failing at nerve terminals, and vesicle accumulation in cell bodies suggested that microtubule-dependent transport is impaired in AD (Suzuki and Terry 1967; Scheff et al. 1990; Praprotnik et al. 1996; Terry 1996; Hirai et al. 2001).”
BackgroundGunawardena, S., & Goldstein, L. S. B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00496-2 · Cited by 428
Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme
Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M.-Y., & Doms, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004175200 · Cited by 402
Hurd, D. D., & Saxton, W. M. (1996) · Genetics · doi:10.1093/genetics/144.3.1075 · Cited by 379
Neurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370
Martin, M., Iyadurai, S. J., Gassman, A., Gindhart, J. G., Hays, T. S., & Saxton, W. M. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3717 · Cited by 365 · cited 4×
“Consistently, mutations in the genes encoding dynein and dynactin as well as kinesin cause accumulations of both anterogradely transported synaptic vesicle precursors and lysosomal organelles within swellings (Gho et al. 1992; Hurd and Saxton 1996; Martin et al. 1999).”
BackgroundInfluentialTrinczek, B., Ebneth, A., Mandelkow, E.-M., & Mandelkow, E. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.14.2355 · Cited by 344
Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302 · cited 4×
“Consistently, the presynaptic terminals of neurons, thought to be the major source of Ab in brain, have been proposed to predominantly secrete Ab that subsequently forms the plaques (Kawarabayashi et al. 1993; Uchihara et al. 1995; Lazarov et al. 2002; Roher et al. 2002; Kamenetz et al. 2003; Smith et al. 2003; Chen e…”
BackgroundInfluentialBuxbaum, J. D., Thinakaran, G., Koliatsos, V., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 293
Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279 · cited 2×
“However, although axonal terminals appear to be sufficient to generate Ab (Kawarabayashi et al. 1993; Uchihara et al. 1995; Lazarov et al. 2002; Roher et al. 2002; Kamenetz et al. 2003; Smith et al. 2003; Chen et al. 2004b), axonal transport kinetics of BACE and PS1 are different from those of APP…”
BackgroundChen, X.-H., Siman, R., Iwata, A., Meaney, D. F., Trojanowski, J. Q., & Smith, D. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63303-2 · Cited by 271 · cited 5×
“…of neurons, thought to be the major source of Ab in brain, have been proposed to predominantly secrete Ab that subsequently forms the plaques (Kawarabayashi et al. 1993; Uchihara et al. 1995; Lazarov et al. 2002; Roher et al. 2002; Kamenetz et al. 2003; Smith et al. 2003; Chen et al. 2004b).”
BackgroundResultInfluentialSingle-molecule investigation of the interference between kinesin, tau and MAP2c
Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.-M., Song, Y.-H., & Mandelkow, E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf503 · Cited by 257 · cited 1×
“The concept of MAPs influencing transport mechanisms is further supported by an in vitro study which demonstrated the direct impact of tau or MAP2c on dynamic parameters of kinesin binding to microtubules (Seitz et al. 2002).”
ResultAxonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited
Lazarov, O., Morfini, G. A., Lee, E. B., Farah, M. H., Szodorai, A., DeBoer, S. R., Koliatsos, V. E., Kins, S., Lee, V. M.-Y., Wong, P. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3089-04.2005 · Cited by 239
Self-citationTorroja, L., Chu, H., Kotovsky, I., & White, K. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80215-2 · Cited by 203 · cited 2×
“swellings with accumulations of organelles and synaptic vesicles (Torroja et al. 1999; Gunawardena and Goldstein 2001) – a phenotype also observed in Drosophila with mutations of kinesin or dynein (Saxton et al.”
BackgroundSaxton, W. M., Hicks, J., Goldstein, L. S. B., & Raff, E. C. (1991) · Cell · doi:10.1016/0092-8674(91)90264-y · Cited by 201 · cited 2×
“…of organelles and synaptic vesicles (Torroja et al. 1999; Gunawardena and Goldstein 2001) – a phenotype also observed in Drosophila with mutations of kinesin or dynein (Saxton et al. 1991; Hurd and Saxton 1996; Hurd et al. 1996; Gindhart et al. 1998; Toyoshima et al. 1998; Martin et al. 1999).”
BackgroundKril, J., Patel, S., Harding, A., & Halliday, G. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0477-5 · Cited by 190
Kinesin Light Chains Are Essential for Axonal Transport in Drosophila
Gindhart, J. G., Desai, C. J., Beushausen, S., Zinn, K., & Goldstein, L. S. B. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.443 · Cited by 179 · cited 1×
“…of organelles and synaptic vesicles (Torroja et al. 1999; Gunawardena and Goldstein 2001) – a phenotype also observed in Drosophila with mutations of kinesin or dynein (Saxton et al. 1991; Hurd and Saxton 1996; Hurd et al. 1996; Gindhart et al. 1998; Toyoshima et al. 1998; Martin et al. 1999).”
BackgroundFine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia
Suzuki, K., & Terry, R. D. (1967) · Acta Neuropathologica · doi:10.1007/bf00688828 · Cited by 169
Stone, J. R., Singleton, R. H., & Povlishock, J. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02485-9 · Cited by 132 · cited 1×
“…et al. 1992; Amaratunga et al. 1993; Morin et al. 1993; Sisodia et al. 1993; Moya et al. 1994; Simons et al. 1995; Yamazaki et al. 1995; Tienari et al. 1996; Yam et al. 1997; Buxbaum et al. 1998; Stone et al. 2000) with a velocity of up to 10 lm per second (Kaether et al. 2000; Stamer et al. 2002).”
BackgroundWirths, O., Multhaup, G., Czech, C., Feldmann, N., Blanchard, V., Tremp, G., Beyreuther, K., Pradier, L., & Bayer, T. A. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00442.x · Cited by 125 · cited 1×
“Increased Ab levels were also found in the white matter of APP/PS1 mutant transgenic mice (Wirths et al. 2002).”
BackgroundBussire, T., Gold, G., Kvari, E., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00942-9 · Cited by 122 · cited 1×
“cells that are prone to neurofibrillary degeneration (Bussiere et al. 2003).”
BackgroundEffects of kinesin mutations on neuronal functions
Gho, M., McDonald, K., Ganetzky, B., & Saxton, W. M. (1992) · Science · doi:10.1126/science.1384131 · Cited by 120
MAP2c, but Not Tau, Binds and Bundles F-Actin via Its Microtubule Binding Domain
Roger, B., Al-Bassam, J., Dehmelt, L., Milligan, R. A., & Halpain, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.01.058 · Cited by 110
Re-Evaluation of the Structural Organization of Neuritic Plaques in Alzheimerʼs Disease
MASLIAH, E., MALLORY, M., DEERINCK, T., DETERESA, R., LAMONT, S., MILLER, A., TERRY, R. D., CARRAGHER, B., & ELLISMAN, M. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00009 · Cited by 105
Cunningham, C. C., Leclerc, N., Flanagan, L. A., Lu, M., Janmey, P. A., & Kosik, K. S. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.4.845 · Cited by 88
Transcriptional and conformational changes of the tau molecule in Alzheimer's disease
Hyman, B. T., Augustinack, J. C., & Ingelsson, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.015 · Cited by 79 · cited 1×
“The exonic missense mutations affect the conformation, phosphorylation and association of tau with enzymes such as protein phosphatase 2A, a tau phosphatase, or fyn, a nonreceptor tyrosine kinase (Goedert et al. 2000; Bhaskar et al. 2005; Hyman et al. 2005).”
BackgroundPHF and PHF-like fibrils –cause or consequence?
Ihara, Y. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00200-1 · Cited by 28 · cited 1×
“The latter may be more pronounced for distal portions of the axon thereby resulting in a slow dyingback process, but leaving the cell body and its proximal portion functional for a fairly long time (Ihara 2001).”
Background
Cited by
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationSynaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
“Synaptotrophic function of human wild-type APP and its failure in FAD-mutated APP Disturbances of synaptic function and plasticity have also been observed in transgenic mice overexpressing FAD- mutated APP [32, 54, 62, 65].”
BackgroundTargeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Mechanisms of axon degeneration: From development to disease
Saxena, S., & Caroni, P. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.007 · Cited by 259
Structural Principles of Tau and the Paired Helical Filaments of Alzheimer's Disease
Mandelkow, E., Von Bergen, M., Biernat, J., & Mandelkow, E. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00053.x · Cited by 243
“So far, a number of different mouse models have been described, resulting in a range of findings that are beyond the scope of this article [for reviews, see (34, 52, 84, 118)].”
Background
Metadata
- Authors
- Götz, J., Ittner, L. M., & Kins, S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-06-19
- Volume
- 98
- Issue
- 4
- Pages
- 993-1006
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2033198098
- Cited by
- 116
- References
- 58
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.